Flamingo Therapeutics Presents at AACR Special Cancer Conference
14 Nov 2024 //
PR NEWSWIRE
Flamingo Highlights MALAT1 Inhibitor FLM-7523 At EACR 2024
10 Jun 2024 //
PR NEWSWIRE
Flamingo Therapeutics Appoints Leading Medical Oncologist Ezra Cohen as MD
21 Mar 2024 //
PR NEWSWIRE
Flamingo Announces Appointment of Andrew E. Denker, MD, PhD, as CMO
04 Apr 2023 //
PR NEWSWIRE
Flamingo Therapeutics and Dynacure Announce Merger
02 Mar 2023 //
PR NEWSWIRE